AP2014007798A0 - Pharmaceutical composition comprising isometamidium chloride in solution for the treatment of trypanosomiasis in animals - Google Patents

Pharmaceutical composition comprising isometamidium chloride in solution for the treatment of trypanosomiasis in animals

Info

Publication number
AP2014007798A0
AP2014007798A0 AP2014007798A AP2014007798A AP2014007798A0 AP 2014007798 A0 AP2014007798 A0 AP 2014007798A0 AP 2014007798 A AP2014007798 A AP 2014007798A AP 2014007798 A AP2014007798 A AP 2014007798A AP 2014007798 A0 AP2014007798 A0 AP 2014007798A0
Authority
AP
ARIPO
Prior art keywords
trypanosomiasis
animals
treatment
solution
pharmaceutical composition
Prior art date
Application number
AP2014007798A
Other languages
English (en)
Inventor
Roviro Alberto Ochoa
Cordero Auristela Gonzalez
Original Assignee
Invest Farmaceuticas Y Veterinarias Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46963763&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2014007798(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Invest Farmaceuticas Y Veterinarias Sl filed Critical Invest Farmaceuticas Y Veterinarias Sl
Publication of AP2014007798A0 publication Critical patent/AP2014007798A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Communication Control (AREA)
AP2014007798A 2012-01-24 2012-07-19 Pharmaceutical composition comprising isometamidium chloride in solution for the treatment of trypanosomiasis in animals AP2014007798A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201230092A ES2416004B1 (es) 2012-01-24 2012-01-24 Composición farmacéutica que comprende cloruro de isometamidium en solución para el tratamiento de la tripanosomiasis en animales.
PCT/ES2012/070550 WO2013110830A1 (es) 2012-01-24 2012-07-19 Composición farmacéutica que comprende cloruro de isometamidium en solución para el tratamiento de la tripanosomiasis en animales

Publications (1)

Publication Number Publication Date
AP2014007798A0 true AP2014007798A0 (en) 2014-07-31

Family

ID=46963763

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2014007798A AP2014007798A0 (en) 2012-01-24 2012-07-19 Pharmaceutical composition comprising isometamidium chloride in solution for the treatment of trypanosomiasis in animals

Country Status (16)

Country Link
AP (1) AP2014007798A0 (es)
AR (1) AR089037A1 (es)
BR (1) BR112014016926A8 (es)
CL (1) CL2014001780A1 (es)
CO (1) CO6990714A2 (es)
CR (1) CR20140278A (es)
DO (1) DOP2014000161A (es)
EC (1) ECSP14010152A (es)
ES (1) ES2416004B1 (es)
GT (1) GT201400159A (es)
MA (1) MA35868B1 (es)
MX (1) MX2014008172A (es)
NI (1) NI201400075A (es)
PE (1) PE20141472A1 (es)
UY (1) UY34479A (es)
WO (1) WO2013110830A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024008B (en) * 1978-06-28 1983-02-16 Merck & Co Inc Compositions for treating trypanosomiasis infections
GB8805286D0 (en) * 1988-03-05 1988-04-07 Schering Agrochemicals Ltd Trypanocides
US5496830A (en) * 1994-09-14 1996-03-05 Johns Hopkins University Inhibition of hemoflagellates by camptothecin compounds
DE19854143A1 (de) * 1998-11-24 2000-05-25 Chambord Ltd Pharmazeutisches Präparat mit trypanozider und blutschizontozider Wirkung
FR2819188B1 (fr) * 2001-01-08 2003-03-14 Virbac Sa Compositions pulverulentes ou granulees hydrosolubles, a base de phenanthridines et leurs utilisations
AR060926A1 (es) * 2007-05-14 2008-07-23 Ciriaco Quiroga Solucion anestesica transparente de propofol, con baja irritacion venosa.
KR20080102010A (ko) * 2007-05-17 2008-11-24 대원제약주식회사 프로포폴을 포함하는 주사제용 조성물 및 이의 제조 방법
DE102008007381A1 (de) * 2008-02-01 2009-08-13 Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten
WO2011042565A2 (en) * 2009-10-09 2011-04-14 Instituut Voor Tropische Geneeskunde Antiprotozoal activity

Also Published As

Publication number Publication date
DOP2014000161A (es) 2014-08-15
CO6990714A2 (es) 2014-07-10
NI201400075A (es) 2015-04-13
BR112014016926A2 (pt) 2017-06-13
UY34479A (es) 2013-07-31
MA35868B1 (fr) 2014-12-01
ECSP14010152A (es) 2015-08-31
WO2013110830A1 (es) 2013-08-01
AR089037A1 (es) 2014-07-23
ES2416004B1 (es) 2014-01-28
BR112014016926A8 (pt) 2017-07-04
GT201400159A (es) 2015-11-19
MX2014008172A (es) 2014-10-06
CR20140278A (es) 2014-12-02
CL2014001780A1 (es) 2014-10-24
ES2416004A1 (es) 2013-07-29
PE20141472A1 (es) 2014-11-05

Similar Documents

Publication Publication Date Title
HK1216105A1 (zh) 治療劑的遞送
IL236221A (en) History of theophyridone and pharmacological preparations containing them for the treatment of diseases
HUE044611T2 (hu) Gyógyászati készítmény rák kezelésére
HK1203977A1 (en) Enhancement of transport of therapeutic molecules across the blood brain barrier
PT2824114T (pt) Composição farmacêutica para o tratamento do cancro
EP2906208A4 (en) THERAPEUTIC TREATMENT
HK1206623A1 (en) Pharmaceutical compositions and treatment of mastitis
HUS2000020I1 (hu) Ciklezonid a légúti betegségek kezelésére lovaknál
IL235058A0 (en) Pharmaceutical combinations for the treatment of metabolic disorders
PL2617445T3 (pl) Układ do zabiegu medycznego
HK1204452A1 (en) Treatment for bone diseases
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease
SI2874600T1 (sl) Farmacevtski sestavek za zdravljenje hripavosti ali bolečin v grlu
GB2502133B (en) Treatment or therapeutic apparatus
IL235272B (en) Alfentanil composition for the treatment of acute pain
GB2515440B (en) Vesicular Formulations for use in the treatment of Rosacea
LT2872176T (lt) Karboranilporfirinai, skirti naudoti vėžio gydymui
EP2866555A4 (en) DOSAGE REGIME FOR THE TREATMENT OF ANIMAL
EP2869796A4 (en) PATIENT TREATMENT SYSTEM
HK1210421A1 (en) Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders -4--20--3-
AP2014007798A0 (en) Pharmaceutical composition comprising isometamidium chloride in solution for the treatment of trypanosomiasis in animals
GB201207476D0 (en) pharmaceutical for the treatment of leishmaniasis
GB201208770D0 (en) Compounds for use in the treatment of adenovirus infections
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds
SI2812351T1 (sl) Farmacevtski sestavek za zdravljenje multiple skleroze